Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Damir Suljević, Amra Šiljak & Muhamed Fočak. (2022) Different outcomes of methadone maintenance therapy in rehabilitated and relapsed drug addicts: significance of liver and renal biomarkers. Drug and Chemical Toxicology 45:1, pages 470-475.
Read now
Read now
Filip Siska, Petra Amchova, Daniela Kuruczova, Yousef Tizabi & Jana Ruda-Kucerova. (2021) Effects of low-dose alcohol exposure in adolescence on subsequent alcohol drinking in adulthood in a rat model of depression. The World Journal of Biological Psychiatry 22:10, pages 757-769.
Read now
Read now
Gabriel C Quintero Garzola. (2020) The Use of Gabapentin for the Treatment of Alcohol and Tobacco Use Disorders: A Review. Open Access Journal of Clinical Trials 12, pages 43-60.
Read now
Read now
M S Zastrozhin, V Yu Skryabin, S S Miroshkin, E A Bryun & D A Sychev. (2019) Pharmacogenetics of alcohol addiction: current perspectives. The Application of Clinical Genetics 12, pages 131-140.
Read now
Read now
Emily E. Hartwell & Henry R. Kranzler. (2019) Pharmacogenetics of alcohol use disorder treatments: an update. Expert Opinion on Drug Metabolism & Toxicology 15:7, pages 553-564.
Read now
Read now
Wenjun Wang, Ying Xu, Chang Jiang & Yanhang Gao. (2019) Advances in the treatment of severe alcoholic hepatitis. Current Medical Research and Opinion 35:2, pages 261-273.
Read now
Read now
Articles from other publishers (61)
Ezequiel Marron Fernandez de Velasco, Megan E. Tipps, Bushra Haider, Anna Souders, Carolina Aguado, Timothy R. Rose, Baovi N. Vo, Margot C. DeBaker, Rafael Luján & Kevin Wickman. (2023) Ethanol-Induced Suppression of G Protein–Gated Inwardly Rectifying K+–Dependent Signaling in the Basal Amygdala. Biological Psychiatry 94:11, pages 863-874.
Crossref
Crossref
R. Miranda Marcos & A. Benyamina. 2023. Remédiation Cognitive. Remédiation Cognitive
373
381
.
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz & Jochen Mutschler. (2022) Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. Frontiers in Pharmacology 13.
Crossref
Crossref
Felicia W. Chi, Sujaya Parthasarathy, Vanessa A. Palzes, Andrea H. Kline-Simon, Verena E. Metz, Constance Weisner, Derek D. Satre, Cynthia I. Campbell, Joseph Elson, Thekla B. Ross, Yun Lu & Stacy A. Sterling. (2022) Alcohol brief intervention, specialty treatment and drinking outcomes at 12 months: Results from a systematic alcohol screening and brief intervention initiative in adult primary care. Drug and Alcohol Dependence 235, pages 109458.
Crossref
Crossref
Waisley Yang, Rohit Singla, Oshin Maheshwari, Christine J. Fontaine & Joana Gil-Mohapel. (2022) Alcohol Use Disorder: Neurobiology and Therapeutics. Biomedicines 10:5, pages 1192.
Crossref
Crossref
Nancy Monroy-Jaramillo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, Alberto Ortega-Vázquez, Janitza Montalvo-Ortiz & Marisol López-López. (2022) The role of alcohol intake in the pharmacogenetics of treatment with clozapine. Pharmacogenomics 23:6, pages 371-392.
Crossref
Crossref
Jing Yuan, Changjiang Wu, Li Wu, Xinxin Fan, Tingting Zeng, Li Xu, Yujun Wei, Yan Zhang, Hongxuan Wang, Ying Peng, Chuanyuan Kang & Jianzhong Yang. (2022) The Association of P300 Components With Clinical Characteristics and Efficacy of Pharmacotherapy in Alcohol Use Disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Yongguang Zhang, Yejie Qiu & Haiyang Zhang. (2022) Computational Investigation of Structural Basis for Enhanced Binding of Isoflavone Analogues with Mitochondrial Aldehyde Dehydrogenase. ACS Omega 7:9, pages 8115-8127.
Crossref
Crossref
Amira Abozaid, Joshua Hung, Benjamin Tsang, Keza Motlana, Reem Al-Ani & Robert Gerlai. (2022) Behavioral effects of acute ethanol in larval zebrafish (D. rerio) depend on genotype and volume of experimental well. Progress in Neuro-Psychopharmacology and Biological Psychiatry 112, pages 110411.
Crossref
Crossref
Natalia A. Quijano Cardé, Erika E. Perez, Richard Feinn, Henry R. Kranzler & Mariella De Biasi. (2021) Antagonism of GluK1-containing kainate receptors reduces ethanol consumption by modulating ethanol reward and withdrawal. Neuropharmacology 199, pages 108783.
Crossref
Crossref
Hiroshi Mitoma, Mario Manto & Aasef G. Shaikh. (2021) Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum. International Journal of Environmental Research and Public Health 18:16, pages 8678.
Crossref
Crossref
Damian Karl, J. Malte Bumb, Patrick Bach, Christina Dinter, Anne Koopmann, Derik Hermann, Karl Mann, Falk Kiefer & Sabine Vollstädt-Klein. (2021) Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder. Psychopharmacology 238:8, pages 2179-2189.
Crossref
Crossref
Erin J. Campbell & Andrew J. Lawrence. (2021) It’s more than just interoception: The insular cortex involvement in alcohol use disorder. Journal of Neurochemistry 157:5, pages 1644-1651.
Crossref
Crossref
Francisco Navarrete, María Salud García-Gutiérrez, Ani Gasparyan, Amaya Austrich-Olivares & Jorge Manzanares. (2021) Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders. Frontiers in Pharmacology 12.
Crossref
Crossref
Miriam Sebold, Maria Garbusow, Deniz Cerci, Ke Chen, Christian Sommer, Quentin JM Huys, Stephan Nebe, Michael Rapp, Ilya M Veer, Ulrich S Zimmermann, Michael N Smolka, Henrik Walter, Andreas Heinz & Eva Friedel. (2021)
Association of the
OPRM1
A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence
. Journal of Psychopharmacology 35:5, pages 566-578.
Crossref
Crossref
Domenic Schnoz & Paolo M. Suter. (2021) CME: Riskanter Alkoholkonsum im Alter. Praxis 110:3, pages 121-130.
Crossref
Crossref
Jelena Milić, Janko Zeković, Dunja Stankić, Ed van Beeck & Janko Samardžić. 2021. Assessments, Treatments and Modeling in Aging and Neurological Disease. Assessments, Treatments and Modeling in Aging and Neurological Disease
91
102
.
Michael Soyka & Susanne Rösner. (2020) Pharmakotherapie der Alkoholentwöhnung: Update und neue EntwicklungenPharmacotherapy of alcohol withdrawal: update and new developments. Der Nervenarzt 92:1, pages 57-65.
Crossref
Crossref
Pablo Berríos-Cárcamo, Mauricio Quezada, María Elena Quintanilla, Paola Morales, Marcelo Ezquer, Mario Herrera-Marschitz, Yedy Israel & Fernando Ezquer. (2020) Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules. Antioxidants 9:9, pages 830.
Crossref
Crossref
Shao-Cheng Wang, Yuan-Chuan Chen, Shaw-Ji Chen, Chun-Hung Lee & Ching-Ming Cheng. (2020) Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review. International Journal of Molecular Sciences 21:17, pages 6413.
Crossref
Crossref
Jeremiah Fairbanks, Audrey Umbreit, Bhanu Prakash Kolla, Victor M. Karpyak, Terry D. Schneekloth, Larissa L. Loukianova & Shirshendu Sinha. (2020) Evidence-Based Pharmacotherapies for Alcohol Use Disorder. Mayo Clinic Proceedings 95:9, pages 1964-1977.
Crossref
Crossref
Ian H Rutkofsky, Kristy A Fisher, Clara L Alvarez Villalba & Samuel Neuhut. (2020) Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review. Cureus.
Crossref
Crossref
Javier Calleja‐Conde, Rosalía Fernández‐Calle, José M. Zapico, Ana Ramos, Beatriz Pascual‐Teresa, Kora‐Mareen Bühler, Victor Echeverry‐Alzate, Elena Giné, Fernando Rodríguez de Fonseca, Jose Antonio López‐Moreno & Gonzalo Herradón. (2020) Inhibition of Receptor Protein Tyrosine Phosphatase β/ζ Reduces Alcohol Intake in Rats. Alcoholism: Clinical and Experimental Research 44:5, pages 1037-1045.
Crossref
Crossref
Erin J. Campbell, Nathan J. Marchant & Andrew J. Lawrence. (2020) A sleeping giant: Suvorexant for the treatment of alcohol use disorder?. Brain Research 1731, pages 145902.
Crossref
Crossref
Maria Petralia, Emanuela Mazzon, Katia Mangano, Paolo Fagone, Roberto Di Marco, Luca Falzone, Maria Basile, Ferdinando Nicoletti & Eugenio Cavalli. (2020) Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders. Experimental and Therapeutic Medicine.
Crossref
Crossref
Bhavani Kashyap, Leah R. Hanson & William H. Frey II. (2020) Intranasal Insulin: a Treatment Strategy for Addiction. Neurotherapeutics 17:1, pages 105-115.
Crossref
Crossref
Otto-Michael Lesch, Henriette Walter, Samuel Pombo, Victor Hesselbrock & Michie Hesselbrock. 2020. Alkohol und Tabak. Alkohol und Tabak
189
270
.
Otto-Michael Lesch, Henriette Walter, Daniel König & Benjamin Vyssoki. 2020. Alkohol und Tabak. Alkohol und Tabak
89
130
.
Giovanni Martinotti, Mauro Pettorruso, Chiara Montemitro, Hamed Ekhtiari, Colleen A. Hanlon, Primavera A. Spagnolo, Elliot Stein & Massimo Di Giannantonio. 2020. Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences. Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences
135
160
.
Otto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, Victor Hesselbrock & Samuel PomboOtto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, Victor Hesselbrock & Samuel Pombo. 2020. Alcohol and Tobacco. Alcohol and Tobacco
195
270
.
Otto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, Victor Hesselbrock & Samuel PomboOtto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, Victor Hesselbrock & Samuel Pombo. 2020. Alcohol and Tobacco. Alcohol and Tobacco
85
127
.
Justin Knox, Deborah S Hasin, Farren R R Larson & Henry R Kranzler. (2019) Prevention, screening, and treatment for heavy drinking and alcohol use disorder. The Lancet Psychiatry 6:12, pages 1054-1067.
Crossref
Crossref
Antonio Ballesta, Francisco Alén, Fernando Rodríguez de Fonseca, Raquel Gómez de Heras & Laura Orio. 2019. Antidepressants - Preclinical, Clinical and Translational Aspects. Antidepressants - Preclinical, Clinical and Translational Aspects.
Bernadett I. Gál, Tünde Kilencz, Anita Albert, Ildikó Demeter, Klára Mária Hegedűs, Zoltán Janka, Gábor Csifcsák & Péter Z. Álmos. (2019) Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control. Frontiers in Pharmacology 10.
Crossref
Crossref
Miroslav Pohanka. (2019) Antidotes Against Methanol Poisoning: A Review. Mini-Reviews in Medicinal Chemistry 19:14, pages 1126-1133.
Crossref
Crossref
Rebecca S. Hofford, Scott J. Russo & Drew D. Kiraly. (2018) Neuroimmune mechanisms of psychostimulant and opioid use disorders. European Journal of Neuroscience 50:3, pages 2562-2573.
Crossref
Crossref
Nazzareno Cannella, Massimo Ubaldi, Alessio Masi, Massimo Bramucci, Marisa Roberto, Angelo Bifone & Roberto Ciccocioppo. (2019) Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neuroscience & Biobehavioral Reviews 103, pages 384-398.
Crossref
Crossref
Amanda Brunchmann, Morgane Thomsen & Anders Fink-Jensen. (2019) The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review. Physiology & Behavior 206, pages 232-242.
Crossref
Crossref
Ana Celia Muñoz-Muñoz, Teresa Pekol, Dana Schubring, Robin Hyland, Charlene Johnson & Lawrence Andrade. (2019) Characterization of an Amphetamine Interference from Gabapentin in an LC–HRMS Method. Journal of Analytical Toxicology.
Crossref
Crossref
Michael Soyka, Jochen Mutschler & Susanne Rösner. (2019) Craving mildern. DNP - Der Neurologe & Psychiater 20:3, pages 42-47.
Crossref
Crossref
Robert A. Waeiss, Christopher P. Knight, Sheketha R. Hauser, Lauren A. Pratt, William J. McBride & Zachary A. Rodd. (2019) Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats. Psychopharmacology 236:6, pages 1887-1900.
Crossref
Crossref
Julia De Ternay, Mickaël Naassila, Mikail Nourredine, Alexandre Louvet, François Bailly, Guillaume Sescousse, Pierre Maurage, Olivier Cottencin, Patrizia Maria Carrieri & Benjamin Rolland. (2019) Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain. Frontiers in Pharmacology 10.
Crossref
Crossref
Nicole A. Crowley, Sarah N. Magee, Mengyang Feng, Sarah J. Jefferson, Christian J. Morris, Nigel C. Dao, Dakota F. Brockway & Bernhard Luscher. (2019) Ketamine normalizes binge drinking-induced defects in glutamatergic synaptic transmission and ethanol drinking behavior in female but not male mice. Neuropharmacology 149, pages 35-44.
Crossref
Crossref
Katherine R. Meckel & Drew D. Kiraly. (2019) A potential role for the gut microbiome in substance use disorders. Psychopharmacology 236:5, pages 1513-1530.
Crossref
Crossref
Thitiporn Supasitthumrong, Blanca M. Bolea‐Alamanac, Selim Asmer, Vincent L. Woo, Petal S. Abdool & Simon J.C. Davies. (2019) Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. British Journal of Clinical Pharmacology 85:4, pages 690-703.
Crossref
Crossref
Christopher T. Rentsch, David A. Fiellin, Kendall J. Bryant, Amy C. Justice & Janet P. Tate. (2019) Association Between Gabapentin Receipt for Any Indication and Alcohol Use Disorders Identification Test-Consumption Scores Among Clinical Subpopulations With and Without Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 43:3, pages 522-530.
Crossref
Crossref
Marco Diana, Corinna Bolloni, Mariangela Antonelli, Daniela Di Giuda, Fabrizio Cocciolillo, Liana Fattore & Giovanni Addolorato. (2019) Repetitive transcranial magnetic stimulation: Re-wiring the alcoholic human brain. Alcohol 74, pages 113-124.
Crossref
Crossref
Jochen Mutschler, Christian A. Müller & Michael Soyka. 2019. Suchtmedizin. Suchtmedizin
93
119
.
Mario Rivera-Meza. 2019. Neuroscience of Alcohol. Neuroscience of Alcohol
171
178
.
Pattarin Chompookham, Warangkana Rukngan, Sumnao Nilaban, Somporn Suwanmajo, Phimpa Yoosom & Rasmon Kalayasiri. (2018) A randomized trial of low-dose gabapentin for post hospitalization relapse prevention in a Thai clinical sample of alcohol dependence. Psychiatry Research 270, pages 34-40.
Crossref
Crossref
Francisco Alen, Juan Decara, Gloria Brunori, Zhi-Bing You, Kora-Mareen Bühler, Jose Antonio López-Moreno, Andrea Cippitelli, Francisco Javier Pavon, Juan Suárez, Eliot L. Gardner, Rafael de la Torre, Roberto Ciccocioppo, Antonia Serrano & Fernando Rodríguez de Fonseca. (2018) PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models. Biochemical Pharmacology 157, pages 235-243.
Crossref
Crossref
M. Carmen Blanco-Gandía & Marta Rodríguez-Arias. (2018) Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years. European Journal of Pharmacology 836, pages 89-101.
Crossref
Crossref
Michael Soyka. (2018) Diagnostik und Therapie der Alkoholabhängigkeit. DNP - Der Neurologe & Psychiater 19:5, pages 53-59.
Crossref
Crossref
Roberta Agabio & Lorenzo Leggio. (2018) Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders. Frontiers in Psychiatry 9.
Crossref
Crossref
María Carmen González-Marín, Sophie Lebourgeois, Jérôme Jeanblanc, Momar Diouf & Mickaël Naassila. (2018) Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking. Neuropharmacology 140, pages 14-24.
Crossref
Crossref
Erin J. Campbell, Andrew J. Lawrence & Christina J. Perry. (2018) New steps for treating alcohol use disorder. Psychopharmacology 235:6, pages 1759-1773.
Crossref
Crossref
Sheraz Khoja, Nhat Huynh, Alicia M. P. Warnecke, Liana Asatryan, Michael W. Jakowec & Daryl L. Davies. (2018) Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders. Psychopharmacology 235:6, pages 1697-1709.
Crossref
Crossref
Carolina L. Haass-Koffler, Robert M. Swift & Lorenzo Leggio. (2018) Noradrenergic targets for the treatment of alcohol use disorder. Psychopharmacology 235:6, pages 1625-1634.
Crossref
Crossref
Sarah Beggiato, Andrea C. Borelli, Maria C. Tomasini, M. Paola Castelli, Nicholas Pintori, Roberto Cacciaglia, Antonella Loche & Luca Ferraro. (2018) In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5. Frontiers in Pharmacology 9.
Crossref
Crossref
Katie Witkiewitz & Kevin E. Vowles. (2018) Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review. Alcoholism: Clinical and Experimental Research 42:3, pages 478-488.
Crossref
Crossref
Jeffrey M. Witkin, Tanya L. Wallace & William J. Martin. 2019. The Nociceptin/Orphanin FQ Peptide Receptor. The Nociceptin/Orphanin FQ Peptide Receptor
399
415
.